tirzepatide for pcos patients PCOS: Tirzepatide Shows Promise for Treatment of Polycystic Ovary Syndrome (PCOS) Your Body Isn't Broken: How

However, caution is warranted as higher rates of adverse events such as symptomatic hypotension, syncope and electrolyte abnormalities were reported in the intensive treatment group

June 25-29

In December 2024, NICE recommended the use of tirzepatide (Mounjaro), alongside semaglutide (Wegovy) and liraglutide (Saxenda), for the treatment of weight-related comorbidities.10 NICE recommended these drugs alongside diet and exercise, yet many patients lack structured programs offering nutritional, behavioural, and psychological support

Never take two doses of Wegovy at the same time to make up for a missed dose

The challenges, though, were not new to specialty medicine, Nguyen said during a presentation